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Human leukocytes can metabolize endogenous arachidonic acid to a variety of 
biologically active compounds important in the regulation of the immune re- 
sponse.  Metabolism via the lipoxygenase pathway results in the synthesis and 
release of leukotrienes (LT), ~ a  unique class of compounds that contain three 
conjugated double bonds, and which may act as soluble mediators in an inflam- 
matory response (1). LTB4 has potent effects on the chemotaxis, chemokinesis, 
and activation of polymorphonuclear leukocytes. LTC4 and its two derivatives, 
LTD4 and LTE4, comprise the slow-reacting substance of anaphylaxis (SRS-A), 
which can cause bronchoconstriction and increased vascular permeability. Stim- 
ulated neutrophils produce predominantly LTB4 (2, 3), whereas LTC4 is a major 
product of eosinophils (4-6). Human monocytes, when appropriately stimulated, 
also metabolize arachidonic acid by the lipoxygenase pathway, with the formation 
of LTB4 and LTC4 (7-9). 
LT also are metabolized by leukocytes. LTB4 metabolism by neutrophils is 
primarily by w-oxidation (10).  Although LTC4 can be metabolized by sequential 
peptide bond cleavage to form LTD4 and LTE4 (1),  LTC4 also is degraded by 
the products of the respiratory burst of stimulated phagocytes. Oxidative deg- 
radation of LTC4 by appropriately stimulated eosinophils (11,  12) and normal 
neutrophils (3, 13, 14) is mediated by the peroxidase-hydrogen peroxide (H202)- 
halide system, and the products formed are the chlorosulfonium ion and sulfoxide 
derivatives of LTC4, and the  6-trans  isomers of LTB4 (13,  14).  LTC4 is also 
degraded by neutrophils that lack peroxidase, i.e., from patients with hereditary 
myeloperoxidase (MPO) deficiency (3). In this instance, degradation appears to 
be dependent on the formation of hydroxyl radicals (OH') by the stimulated 
cells (3,  15). 
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Monocytes possess a granule peroxidase identical to the MPO of neutrophils, 
and respond to stimulation with a respiratory burst leading to the formation of 
H20~ (16).  Monocytes, derived from peripheral blood and maintained as adher- 
ent cells in culture, undergo a variety of biochemical and morphologic changes, 
and differentiate into cells resembling tissue macrophages. During this transfor- 
mation in culture, there is a progressive loss of the granule peroxidase (17,  19); 
H202  release,  following a  rise  at day  3,  also falls sharply (20).  Treatment of 
monocyte-derived macrophages with y-interferon (IFN-3,)  results in their acti- 
vation, with a concommitant increase in H202 generation when stimulated (21). 
These changes in two key components (MPO,  H202) of a  system previously 
demonstrated to degrade LTC4 might be expected to be reflected in the ability 
of mononuclear phagocytes to  degrade  LTC4.  In  this  study, we  report  that 
freshly isolated human monocytes are capable of degrading [LTC4 when stimu- 
lated, and that this degradative activity is markedly decreased during time in 
culture, unless MPO  is added.  IFN-3' supplementation of the medium during 
days 6-9 in culture augmented I.TC4 degradation in the presence but not in the 
absence of added MPO. 
Materials and Methods 
Special Reagents.  Phorbol myristate acetate (PMA) and Histopaque 1077 were obtained 
from Sigma Chemical Co. (St. Louis, MO); the calcium ionophore, A23187, was obtained 
from Calbiochem-Behring  (San Diego, CA); superoxide  dismutase (lyophilized powder 
from bovine erythrocytes;  12,300 U]mg)  from Miles Laboratories,  Inc. (Elkhart,  IN); 
zymosan from Nutritional  Biochemicals (Cleveland, OH); N-formyl-methionine-leucine- 
phenylalanine (FMLP) from Peninsula Laboratories  (Belmont, CA), 14,15-[3H(N)]LTC4, 
35.7 Ci/mmol from New England Nuclear (Boston, MA); and catalase (from bovine liver; 
60,000  U/rag) from Worthington Biochemical Corp.  (Freehold,  NJ). The catalase was 
dialyzed against sterile nonpyrogenic water before use. RPMI  1640 with Hepes buffer 
was obtained from Whittaker M. A. Bioproducts (Walkersville, MD), and supplemented 
with L-glutamine (0.2 mM), penicillin (25  U/ml) and streptomycin  (25  gg/ml) (Gibco 
Laboratories,  Grand Island, NY). MPO was purified from canine pyometrial pus by the 
method of Agner (22) to the end of step 6, and assayed by guaiacol oxidation (23). For 
the preparation of autologous or AB serum, whole blood was allowed to clot for 30-60 
min at room temperature, and the supernatant was collected after centrifugation and 
frozen at -70°C until  use. Synthetic  LTC4 was kindly provided  by J.  Rokach,  Merck 
Frosst  Laboratories  (Pointe-Claire/Dorval,  Quebec,  Canada).  5-hydroxyeicosatetranoic 
acid  (HETE)  and  12-HETE  were  from  W.  Hubbard,  National  Institutes  of Health 
(Bethesda, MD), and recombinant human IFN-3' was provided  by P. Trown, Hoffman- 
LaRoche (Nutley, NJ). IFN-3' activity was determined by the supplier in a WISH/VSV 
cytopathic effect microtiter assay standardized with NIH human IFN-3, reference standard 
Gg 23-901-530. 
All media and buffers were prepared in sterile, nonpyrogenic  water (Travenol  Labo- 
ratories,  Inc.  (Deerfield,  IL),  and were  filtered before use  with  0.22-~m filter units 
(Sybron/Nalge  (Rochester, NY). All glassware was heated at 170°C for 24 h to destroy 
endotoxin. 
Preparation of Monocyte Cultures.  Venous blood was obtained after informed consent 
from  14  healthy human volunteers,  a patient with hereditary MPO  deficiency, and a 
patient with  chronic  granulomatous disease (CGD), all  of whom  had  not  taken any 
medication,  including aspirin or other nonsteroidal  antiinflammatory agents, for 1 wk. 
Immediately  after collection, the anticoagulated (0.5% K-EDTA) whole blood was diluted 
1:1 (vol/vol) with cold calcium and magnesium-free phosphate-buffered  saline (PD), and 
centrifuged at 125 g for 20 rain at 4°C. The cells were washed twice with PD, resuspended 1636  MONOCYTES  OXIDIZE  LEUKOTR1ENE  C4 
in  warm  PD  containing  0.3  mM  Na-EDTA,  underlayered  with  cold  Histopaque  1077 
(1.5:1, cell suspension/Histopaque, vol/vol), and centrifuged at 800 g at 23 °C for 25 min 
(24).  Mononuclear cells removed from the PD/Histopaque interface were washed twice 
with PD at 23°C and resuspended in  RPMI  1640  with  15% autologous serum (or in a 
few instances, AB serum) at a concentration of 2-3  x  106 monocytes/ml. Viability was 
>92%, as judged by trypan blue exclusion. Monocytes added to sterile 60 ×  15 mm tissue 
culture plates (Costar, Cambridge, MA) in a 3-4-ml volume were allowed to adhere for 2 
h  in  humidified  5%  CO2/95%  air at 37°C.  To remove nonadherent  cells,  plates were 
washed 6-8  times with warm sterile phosphate-buffered saline containing calcium and 
magnesium (PBS), and fresh RPMI with  15% autologous serum was added. The cultures 
were maintained in 5% COJ95% air with humidity at 37°C, with fresh media added the 
day after isolation and every other day thereafter.  Some monolayers were stained with 
Diffquik (Difco Laboratories, Detroit, MI) for determination of morphologic detail, and 
for peroxidase (25).  Cell number was determined with an ocular micrometer. 
Monolayers  supplemented  with  IFN-3,  had  fresh  medium  containing  recombinant 
human  IFN-3' at  100  U/ml added  on days 6,  7,  and  8.  Control  monolayers had  fresh 
medium alone added at similar times. PMA stimulation was performed on day 9. 
Cell Incubations.  At specified intervals after adherence, monolayers were washed 6-8 
times with warm sterile Tyrode's buffer. Reaction mixtures, containing the components 
described in the Figures and Tables, were added in a final volume of 3 ml of Tyrode's 
buffer, and the tissue culture plates were incubated at 37°C in  5% CO2/95% air for 30 
min,  unless  otherwise  specified.  All  stimuli  except  zymosan  were  stored  in  dimethyl 
sulfoxide (DMSO) at -70°C, and were diluted with Tyrode's buffer immediately before 
use.  The final concentration  of DMSO  was  0.02%.  At the  end  of the  incubation,  the 
reaction mixtures were removed from the plates and centrifuged at 200 g for 10 min at 
10 ° C. The supernatants were extracted on 1 ml octadecyl Baker-10 columns (J. T. Baker 
Chemical Co., Phillipsburg,  NJ), and stored at -20°C until further processing. Samples 
were evaporated to dryness  under  nitrogen,  suspended  in  methanol/water/acetic acid 
(75:25:0.01,  vol/vol/vol), pH 4.7, centrifuged at 3,000 g for 5 rain at 4°C, and the clear 
supernatant was applied to a 4.6 ×  250 mm Ultrasphere ODS C~8 column (5 #m particle 
size; Beckman Instruments, Inc., Berkeley, CA). Reverse-phase high-performance liquid 
chromatography (HPLC) was subsequently performed using the same solvent at a  flow 
rate of 1 ml/min (3).  Peaks at 235 nm and 280 nm, which coeluted with authentic  LT 
and HETE standards, were rechromatographed on a 4.6 ×  75 mm Beckman Ultrasphere 
ODS C~8 column (3/~m particle size), using the same solvent" at a flow rate of 1.6 ml/min. 
Identified peaks were quantitated  as previously described  (3).  Radioactivity was deter- 
mined with a Beckman model LS 100 C liquid scintillation counter. 
Statistical Analyses.  Data from different experiments were combined and reported as 
the  mean +  SE.  Student's two-tailed t-test for independent  means was used  to analyze 
differences for significance (p >  0.05 considered not significant). 
Results 
Characteristics  of the Monolayers.  >98%  of the ceils of freshly (2  h) adherent 
monolayers had typical monocyte morphology when examined by light micros- 
copy using  Diffquik  staining;  >95%  of the  cells  were  peroxidase-positive.  No 
neutrophils were observed in these preparations. 
To  assess  the  degree  of  platelet  contamination  (7,  8),  supernatants  from 
A23187-stimulated  cell  preparations  were  analyzed  by  HPLC  for  5-HETE 
and  12-HETE,  which  are  products  of monocytes  and  platelets,  respectively. 
When  mononuclear  suspensions  (before  adherence)  were  stimulated  with 
A23187  (1  #g/ml),  more  12-HETE  than  5-HETE  was  formed,  with  the 
5-HETE/12-HETE  ratio  being  0.3  -+  0.5  (n  =  7).  The  12-HETE  level  was 
considerably reduced when monolayers were stimulated after adherence for 2 h, NEILL ET  AL.  1637 
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FIGURE  |.  LTC4 degradation by normal monocytes. 2-h adherent human monocytes (5-8 x 
106) were incubated in 3 ml of Tyrode's  buFFer containing 400 ng LTC4 (100,000 cpm of 
[3H]LTC4) in the absence (A) or presence (B) of PMA (1  #g/ml) for 30 min at 37°C in 5% 
CO~/95% air. The reaction mixtures were analyzed by HPLC, as described in Materials and 
Methods,  and sequential  l-m] eluates  were assayed for [3H]LTC4. Compound  l  is LTC4, 
compound  II is 5-(S),  12-(R)-6-trans-LTB4, and compound III is 5-(S),12-(S)-6-trans-LTB4. 
with  the  5-HETE/12-HETE  ratio increasing to  5.5  +  1.1  (n  =  7).  The  18-fold 
increase in the ratio of 5-HETE/12-HETE  was taken as evidence of platelet loss 
during the adherence process. 
Degradation of LTC4.  When  monocytes, isolated from freshly drawn  human 
blood and allowed to adhere to plastic tissue culture dishes for 2 h, were incubated 
with LTC4 for 30 rain,  little degradation  of the added  LTC4 occurred (Fig.  1 A 
and  Table  I).  In  contrast,  when  the  monolayers were stimulated  with  PMA (1 
#g/ml),  88.9%  of the  added  LTC4  was degraded  (Fig.  1 B  and  Table  I).  The 
major degradation  products  were  the  two all-trans-isomers of LTB4,  5-(S),12- 1638  MONOCYTES  OXIDIZE  LEUKOTRIENE  C4 
TABLE  I 
Effect of lnhibitors on LTC4 Degradation by Normal Human Monocytes 
LTC4 degradation  Significance (p)  Significance (p) 
vs. PMA-stimu-  Supplements  (%)*  vs. control 
lated ceils 
None  8.6 +  1.0  (4)  --  <0.001 
PMA (1  gg/ml)  88.9 ±  4.2  (6)  <0.001  -- 
PMA +  catalase (60 #g/ml)  7.0 ±  7.0  (2)  NS*  <0.001 
PMA +  catalase (heated)  42.5 ±  7.5  (2)  <0.01  <0.002 
PMA +  azide (10 -4 M)  0  ±  0  (2)  NS  <0.001 
PMA +- SOD§ (5 #g/ml)  81.0 ±  1.0  (2)  <0.001  NS 
2-h adherent monocyte cultures were incubated with LTC4 as described in Fig.  1, except that the 
supplements were added at the concentrations shown. Catalase was heated at  100°C  for  15  rain 
where indicated. 
* Mean --+- SE. Number of experiments (n) given in parentheses. 
* NS, not statistically significant. 
§ SOD, superoxide dismutase. 
(R)-6-trans-LTB4,  and  5-(S),12-(S)-6-trans-LTB4,  which together accounted for 
46.8%  of the radioactivity of the added  [~H]LTC4 (Fig.  1B). The degradation 
of LTC4 by PMA-stimulated monocytes was greatly inhibited by the hemeprotein 
inhibitor,  azide,  and by catalase,  which scavenges H202,  heat  treatment  of the 
catalase  decreased  but  did  not  abolish  its  inhibitory  effect.  Degradation  was 
unaffected by superoxide dismutase (Table I).  These findings suggest that  the 
degradation  of LTC4 by PMA-stimulated monocytes is due to the action of the 
MPO-H202 system. Studies with MPO-deficient monocytes supported this con- 
clusion (Fig.  2).  2-h adherent  MPO-deficient monocytes did not degrade LTC4 
when  stimulated  by PMA  under  conditions  in  which  normal  monocytes were 
highly effective (Fig.  2A). The addition of purified MPO to the MPO-deficient 
monocytes before stimulation  by PMA resulted in the complete degradation  of 
the added LTC4 (Fig. 2B). This effect was abolished by heating the MPO before 
adding it to the reaction mixture.  As with normal  monocytes, the major degra- 
dation  products  of LTC4 produced by PMA-stimulated  MPO-deficient  mono- 
cytes supplemented with MPO were the two all-trans  isomers of LTB4.  Freshly 
isolated monocytes from a patient with CGD did not degrade added LTC4 either 
in the presence or absence of stimulation with PMA (data not shown). 
Stimuli of the respiratory burst other than PMA were also capable of inducing 
LTC4 degradation of 2-h adherent monocytes (Table II). The calcium ionophore 
A23187 increased degradation  from 8.6%  to 27.2%, and the synthetic peptide 
FMLP,  when  combined  with  cytochalasin  B,  produced  30.9%  degradation. 
Cytochalasin B or FMLP alone at the concentrations used had no effect. Opson- 
ized zymosan centrifuged onto the monolayer produced 71.6%  degradation  of 
the  added  LTC4,  as compared  to  16.9%  for the  centrifuged  control.  DMSO, 
which was used as the solvent for all of the stimuli except opsonized zymosan, 
had no effect on  LTC4 recovery from unstimulated  monolayers at the concen- 
tration used (0.02%). 
Human monocytes maintained in culture gradually lost their ability to degrade 
LTC4  (Fig.  3).  Degradation  by monolayers  stimulated  with  PMA  for  30  min 
decreased from 88.9% at 2 h, to 52.5% at 1 d, to 7.5% at 3 d, and to 0% at 5 d. ~0005 
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FIGURE  2.  LTC4 degradation  by MPO-deficient  monocytes. The monolayer cultures in both 
(A)  and  (B)  were  incubated  with  PMA  as  described  in  Fig.  I,  except  that  MPO-deficient 
monocytes  were used and  228  mU/ml  of MPO  were added  in (B). 
This decrease in LTC4 degradation by monocytes with time in culture correlated 
with a loss in endogenous peroxidase activity (20). When MPO was added to the 
reaction mixture, stimulation of 3-d adherent monocytes for 30 rain with PMA 
resulted in  the complete degradation  of added  LTC4 (Fig.  2), with 92%  of the 
radioactivity added as LTC4 being degraded to the two all-trans isomers of LTB4. 
The addition of MPO to control cultures (i.e., in the absence of PMA) on day 3 
increased  LTC4 degradation  from 7.5  to  14.8%.  At 5  d  in culture, addition of 
MPO resulted in 55% degradation of LTC4 under these conditions. 
IFN-3,  increases  H202  production  by  stimulated  monocyte-derived  macro- 
phages (21).  Supplementation of the culture medium with recombinant  human 
|FN-3,  for  3  d  before  stimulation  with  PMA  on  day 9  had no effect  on  LTC4 
degradation (Table III). However, wben MPO was added to the reaction mixture, 
IFN-t,  supplementation  significantly  augmented  LTC4  degradation  by  PMA- 1640  MONOCYTES  OXIDIZE  LEUKOTRIENE  C4 
TABLE  II 
Effect of Various Stimuli on LTC4 Degradation by Normal Human 
Monocytes 
Stimuli  LTC4 degradation  Significance (p) 
(%)*  vs. control  s 
None (uncentrifuged)  8.6 +  1.0 (4)  -- 
PMA (1 #g/ml)  88.9 +  4.2 (6)  <0.001 
A23187 (1  ug/ml)  27.2 +- 4.6 (3)  <0.01 
FMLP (10 -6 M)  7.5 --- 3.2 (2)  NS 
FMLP (10 -~ M)  7.3 ___  1.1 (2)  NS 
FMLP (10  -6 M) + cytochalasin B  50.9 +  8.2 (3)  <0.05 
(10 -~ M) 
None (centrifuged)  16.9  --- 1.4 (2)  -- 
Zymosan (opsonized; 1 mg/ml)  71.6 _  9.2 (2)  <0.01 
2-h adherent monocyte cultures were incubated with LTC4 as described 
in  Fig.  1,  except  that  the  stimuli  indicated  above  were  employed. 
Zymosan, opsonized by incubation with pooled normal human serum 
for  15  rain at  37°C and washed free of unbound serum components, 
was centrifuged onto the  monolayer (125  g  for  5  min at  23°C)just 
before incubation; control monolayers were centrifuged under identical 
conditions in the absence of added zymosan where indicated. 
* Mean -  SE. Number of experiments (n) given in parentheses. 
* Opsonized zymosan was compared to the centrifuged control. NS, not 
statistically significant. 
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FtGUP.E  3.  Degradation of LTC4 by normal human monocyte-derived macrophages. Mono- 
layers maintained in culture for the periods indicated were incubated with LTC4 and PMA as 
described in Fig. 1 (Q). Where indicated (O), 228 mU/ml of MPO were added at the beginning 
of the 30 rain stimulation period. 
stimulated macrophages, increasing degradation from 69.5 to 95.6%. The major 
degradation products were the two all-trans isomers of LTB4. 
Discussion 
We report here that freshly isolated normal human monocytes maintained  as 
monolayer cultures  degrade  exogenous  LTC4  when  stimulated  by PMA,  and 
that  degradation  occurs by a  mechanism  involving both MPO and  H202. The 
evidence for the latter is as follows: (a) Degradation was inhibited by azide (which NEILL  ET  AL. 
TABLE  III 
Effect of lFN-~, on LTC4 Degradation by Normal Monocyte-derived Macrophages 
1641 
LTC4 degradation (%)*  Significance 
Supplements 
Without IFN  With IFN  (p)at 
PMA  6.5 --- 6.4 (2)  4.8 +  0.25 (2)  NS 
PMA +  MPO  69.5 +  5.9 (2)  95.6 4- 0.75 (2)  <0.05 
Adherent mononuclear phagocytes maintained in culture for  6  d  were supplemented with  100 
U/ml of recombinant human  IFN-3, for  3  d,  where indicated.  On  day 9,  the monolayers were 
stimulated with PMA, as described in Fig.  1, in the presence or absence of MPO (228 mU/ml). 
* Mean -+ SE. Number of experiments (n) given in parentheses. 
* Significance between cells cultured in the presence and absence of I FN-3,. 
can inhibit  MPO) and by catalase (which degrades  H202),  but not by heated 
catalase.  (b)  MPO-deficient  monocytes did  not  degrade  added  LTC4  when 
stimulated unless purified MPO was added. (c) CGD monocytes (which lack a 
respiratory burst and thus do not form H202)  did not degrade LTC4.  (d) The 
cell-free MPO-H202-halide system rapidly degrades LTC4 (11,  13,  14). 
In contrast to our findings with MPO-deficient monocytes, neutrophils from 
patients with MPO deficiency degrade LTC4 when stimulated, and OH-  gener- 
ated by the Haber-Weiss reaction appears to be involved in this degradation (3). 
This difference may be due to the higher cell numbers (2.0  X  107) used in the 
neutrophil studies than in the monocyte studies reported here (5-8  X  106), and 
to the considerably greater respiratory burst of neutrophils as compared with 
monocytes on a per-cell basis (26). 
The calcium ionopbore, A23187;  the chemotactic factor, FMLP, when com- 
bined with cytochalasin B; and the phagocytosable particle, opsonized zymosan, 
could replace  PMA as  the  monocyte stimulus.  The  major products of LTC4 
degradation by normal human monocytes after incubation with each stimulus 
were the two all-trans isomers of LTB4, 5-(S), 12-(R)-6-trans-LTB4 and 5-(S),12- 
(S)-6-trans-LTB4.  These metabolites were also produced when  MPO-deficient 
monocytes supplemented with  MPO  were used.  Other  metabolites of LTC4, 
namely the chlorosulfonium ion and sulfoxide derivatives, have been proposed 
(13, 14) as products of the oxidation of LTC4 by the peroxidase system, and our 
studies do not exclude their formation by stimulated monocytes. In one study 
(9) in which the degradation of LTB4 and LTC4 by calcium ionophore A23187- 
stimulated monocytes was assessed, no catabolism was detected. The numbers of 
monocytes per monolayer in our study was 2-3 times that employed by Williams 
et al.  (9),  which may account for their inability to detect LTC4 degradation by 
ionophore-stimulated human monocytes. 
After 3 d in culture as adherent cells, normal monocyte-derived macrophages 
lose their ability to degrade LTC4.  The loss  of this degradative capacity is in 
parallel  with  the loss  of granule peroxidase from the ceils (20).  Although the 
amount  of  H202  produced  by  stimulated  monocyte-derived macrophages  is 
maximal by the third day in culture (20),  our studies suggest that the amount 
produced is insufficient to degrade LTC4 in the absence of MPO. When stimu- 
lated cells are supplemented with MPO on day 3, complete degradation of LTC4 
occurs. At later times (days 5 and 9) under these same conditions, only ~60% of 1642  MONOCYTES OXIDIZE LEUKOTRIENE C4 
the added  LTC4  is  degraded by stimulated cells, and this  may be due to  the 
reduction in H202 production as these cells mature. 
IFN-y is a  potent cytokine, which activates macrophages. One of the conse- 
quences of the activation of human monocyte-derived macrophages is an increase 
in  HzO2  production  by stimulated cells (21).  Supplementation of the  culture 
medium of monocyte-derived macrophages  with  recombinant  IFN-y  had  no 
effect on LTC4 degradation in the absence of peroxidase. However, the addition 
of MPO to PMA-stimulated cells produced a significantly greater degradation of 
LTC4 when the monolayers were pretreated with IFN-y. 
The degradation of LTC4 by the peroxidase-H202-halide system yields prod- 
ucts with considerably less  SRS-A activity than the parent compound (11,  13, 
14, 27, 28). Peroxidase-containing phagocytes, i.e., neutrophils, eosinophils, and 
monocytes, would be expected to directly influence SRS-A activity through the 
release of their peroxidase and H202.  Modulation of leukotriene activity in an 
inflammatory lesion might also occur through the reaction of released peroxidase 
with HzO2  generated by a  peroxidase-negative phagocyte such as the macro- 
phage.  Amplification of this  latter effect could occur if the  H202-generating 
capacity of the macrophage is increased by activation with IFN-y. 
Summary 
Freshly isolated  2-h  adherent  normal  human  monocytes, when  stimulated, 
degrade added leukotriene C4 (LTC4) by a myeioperoxidase (MPO) and HzO2- 
dependent mechanism. Among the stimuli effective in this regard are phorbol 
myristate acetate (PMA), the calcium ionophore A23187,  opsonized zymosan, 
and  N-formyl-methionine-leucine-phenylalanine (FMLP)  when  combined with 
cytochalasin B. The predominant products formed are the all-trans isomers of 
LTB4,  5-(S), 12-(R)-6-trans-LTB4 and 5-(S),12-(S)-6-trans-LTB4.  Degradation is 
inhibited by azide and catalase, but not by superoxide dismutase. LTC4 degra- 
dation does not occur when MPO-deficient monocytes are used, unless MPO is 
added. Stimulated monocytes from patients with chronic granulomatous disease 
also are unable  to  degrade  LTC4  under these conditions.  Normal  monocytes 
maintained in culture lose their ability to degrade LTC4. The addition of MPO 
to monocyte-derived macrophages increases degradation, particularly when the 
monolayers are pretreated with y-interferon. The oxidative degradation of LTC4 
is a  capacity shared by neutrophils, eosinophils, and mononuclear phagocytes, 
and may be an important mechanism for the modulation of leukotriene activity 
in inflammatory lesions. 
We thank G. Chiang,  A. Waltersdorph,  and V. Shigakane for their excellent technical 
assistance, and C. Wilson for secretarial support. 
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